Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,485-8,496 of 23,847
Drug study icon
CompletedNCT00240721

Effectiveness of effectiveness and Safety of Topiramate in Bipolarity

This study is completed. It is testing effectiveness and Safety of Topiramate for Bipolarity.

Location not clearly listed
Bipolarity, SchizophreniaDrugA study involving a medication or substance.Over 16 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00649064

Effects of Ziprasidone for schizophrenia

This study is completed in Taiwan. It is testing effects of Ziprasidone for schizophrenia.

Multiple locations, including Changhua
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00111189

Effectiveness of efficacy (Effectiveness) of Paliperidone Palmitate in schizophrenia

This study is completed in the United States, in Costa Rica, in Mexico, .... It is testing efficacy (Effectiveness) of Paliperidone Palmitate for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Costa Rica, Mexico, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01617187

Asenapine for schizophrenia

This study is completed. It is testing asenapine for schizophrenia.

Location not clearly listed
SchizophreniaDrugOver 18 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Drug study icon
CompletedNCT00644800

Intramuscular Ziprasidone Followed by Oral Ziprasidone for Schizophrenia

This study is completed in Brazil. It is testing intramuscular Ziprasidone Followed by Oral Ziprasidone for Schizophrenia.

Multiple locations, including Fortaleza
Schizophrenia, BipolarityDrugFrom 18 Years to 55 Years
Countries
Brazil
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00236444

Risperidone for ADHD

This study is completed. It is testing risperidone for ADHD.

Location not clearly listed
ADHDDrugFrom 5 Years to 17 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
ADHD
Drug study icon
Active Not RecruitingNCT06254612

SP-624 for depression

This study is active but not recruiting in the United States. It is testing SP-624 for depression.

Multiple locations, including Phoenix
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.